(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Sydney Sweeney's American Eagle campaign and Kendrick Lamar's Super Bowl performance were among the 10 biggest pop-culture moments of 2025 - 2Foods with healthy-sounding buzzwords could be hiding added sugar in plain sight
- 3Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks
- 4Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
- 5Peruvian ex-President Martin Vizcarra sentenced to 14 years in prison
- December’s full moon is the last supermoon of the year. Here’s what to know
- 8 key takeaways from Savannah Guthrie's 'Today' interview on the disappearance of her mother
- Vote In favor of Your Favored Language Interpretation Administration
- Pacific voyagers’ remarkable environmental knowledge allowed for long-distance navigation without Western technology
- Find the Mysteries of Effective Objective Setting: Transforming Dreams into Feasible Targets
- Little Italy Mercato brings fresh food and community to downtown San Diego
- NASA releases stunning new images captured by the Artemis II moon mission, including 'Earthset' and a solar eclipse from space
- Boeing's troubled capsule won't carry astronauts on next space station flight
- Met Gala 2026 will celebrate fashion as an 'embodied art form': A guide to the theme, dress code, cochairs and hosting committee of the starry event
